A 28-year-old male traveller returns from endemic malaria region in West Bengal with fever, jaundice, and dark urine. Thick blood smear shows parasitaemia of 2.5%. Severe malaria with acute kidney injury is suspected. Which investigation is most appropriate to assess the severity of malaria and guide intensive management?

Explanation

## Investigation of Choice for Assessing Malaria Severity ### Criteria for Severe Malaria and Prognostic Markers **Key Point:** Severe malaria is defined by presence of one or more complications: cerebral malaria, severe anaemia (Hb <7 g/dL), renal failure (creatinine >3 mg/dL), pulmonary oedema, hypoglycaemia, metabolic acidosis, or parasitaemia >1% [cite:Harrison 21e Ch 219]. **High-Yield:** In the case presented: - Parasitaemia of 2.5% = **severe malaria** (>1%) - Jaundice + dark urine = hepatic and renal involvement - AKI = one of the major complications ### Why Quantitative Parasitaemia + Lactate Level is the Best Investigation **Parasitaemia Assessment:** - Quantitative thick smear (parasites/μL or % of RBCs infected) is the most direct measure of parasite burden - Parasitaemia >1% is a criterion for severe malaria; >5% indicates very high mortality risk - Repeat smears every 6–12 hours during treatment monitor parasite clearance and treatment response **Lactate Level Measurement:** - Lactate is a marker of tissue hypoxia and metabolic acidosis in severe malaria - Elevated lactate (>5 mmol/L) indicates severe metabolic derangement and poor prognosis - Lactate clearance predicts treatment response and organ recovery better than parasitaemia alone - Directly guides intensity of supportive care (mechanical ventilation, vasopressors, dialysis) **Clinical Pearl:** The combination of parasitaemia quantification + lactate level provides both the **burden of infection** and the **severity of systemic derangement** — essential for prognostication and intensive care triage in severe malaria. ### Severity Assessment Table | Parameter | Normal | Mild–Moderate | Severe | | --- | --- | --- | --- | | **Parasitaemia (%)** | <0.1 | 0.1–1 | >1 | | **Lactate (mmol/L)** | <2 | 2–5 | >5 | | **Creatinine (mg/dL)** | <1.5 | 1.5–3 | >3 | | **Hb (g/dL)** | >10 | 7–10 | <7 | | **Mortality risk** | <1% | 5–10% | >20% | ### Why Other Investigations Are Inadequate **Repeat Thick and Thin Smear Every 6 Hours:** While serial smears monitor parasite clearance, they do NOT assess systemic severity or metabolic derangement; smear alone cannot guide ICU admission or organ support decisions. **RDT with Blood Glucose:** RDT is a screening tool and does not quantify parasitaemia; hypoglycaemia is a complication but glucose alone does not assess overall severity or guide prognosis. **QBC with Reticulocyte Count:** QBC is rapid but does not quantify parasitaemia reliably; reticulocyte count assesses bone marrow response to anaemia but does not reflect acute severity or metabolic derangement. **Mnemonic:** **SLAM** = **Severity assessment, Lactate, Antigen/parasitaemia, Metabolic markers** → Quantitative parasitaemia + lactate captures severity in severe malaria.